VeriMomIst dihydroartemisinic acid in der Schwangerschaft sicher?
No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
Related ingredients
Frequently asked questions
- Ist dihydroartemisinic acid in der Schwangerschaft sicher?
- No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- Ist dihydroartemisinic acid während des Stillens sicher?
- Same evidence base as pregnancy: no regulatory or peer‑reviewed data indicating reproductive or lactation-specific hazard for DHAA. With no data of transfer into milk for DHAA, exposure scoring follows the adult topical route (low but measurable dermal absorption, e=1). No breastfeeding‑specific studies were found. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- Ist dihydroartemisinic acid sicher für Babyhaut?
- No infant‑specific toxicity or developmental dermatotoxicity data were found. Following your rules, because adult topical exposure is scored as measurable (e=1) and the compound is moderately lipophilic (logP ~3.7, MW 236) infant exposure is increased by +1 for immature barrier/higher SA:BW, giving e=2. Hazard and mechanism remain 0 in absence of reproductive/ED/teratogenic evidence. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- Wie bewertet VeriMom dihydroartemisinic acid?
- VeriMom bewertet dihydroartemisinic acid mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu dihydroartemisinic acid?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu dihydroartemisinic acid basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.